Dr. Offodile joins MSK from the University of Texas MD Anderson Cancer Center in Houston, where he worked as the enterprise executive director for clinical trial transformation and was a member of the plastic surgery department.
In his new role at MSK, Dr. Offodile will oversee strategy and care transformation initiatives “by continuing to develop the core infrastructure, management systems, and processes for enterprise strategy and business development,” according to a news release. He specializes in oncologic reconstruction and will also see patients on a limited basis.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
